Clinical Trials
2
Active:1
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Pilot Study of Terazosin for Parkinson's Disease
Phase 1
Completed
- Conditions
- Parkinson Disease
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2019-04-05
- Last Posted Date
- 2022-05-16
- Lead Sponsor
- Jordan Schultz
- Target Recruit Count
- 13
- Registration Number
- NCT03905811
- Locations
- 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Neurobiological Predictors of Huntington's Disease (PREDICT-HD)
Active, not recruiting
- Conditions
- Huntington Disease
- First Posted Date
- 2003-01-09
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Jordan Schultz
- Target Recruit Count
- 1700
- Registration Number
- NCT00051324
- Locations
- 🇺🇸
University of Iowa, Iowa City, Iowa, United States
News
No news found